A biotechnology company dedicated to exploring the vast potential of molecular and synthetic biology, StrainX Bio has secured $13.0M in new investment. The funding round saw participation from Prime Venture and Leo Capital.
StrainX specializes in engineering biological systems through precision fermentation and other advanced techniques. Its interdisciplinary team develops proprietary proteins, enzymes, and metabolites, aiming to create groundbreaking solutions for industries spanning food, healthcare, agriculture, and industrial applications.















